Q1 Earnings Forecast for Innospec Issued By Seaport Res Ptn

Innospec Inc. (NASDAQ:IOSP) – Seaport Res Ptn boosted their Q1 2025 earnings per share estimates for Innospec in a note issued to investors on Monday, April 21st. Seaport Res Ptn analyst M. Harrison now expects that the specialty chemicals company will earn $1.39 per share for the quarter, up from their previous estimate of $1.38. Seaport Res Ptn currently has a “Strong-Buy” rating on the stock. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share.

Separately, StockNews.com cut shares of Innospec from a “buy” rating to a “hold” rating in a research note on Wednesday, April 2nd.

Innospec Stock Performance

Shares of Innospec stock opened at $88.44 on Wednesday. The firm has a 50-day moving average of $95.76 and a 200-day moving average of $107.45. Innospec has a 52-week low of $80.32 and a 52-week high of $133.71. The stock has a market cap of $2.22 billion, a PE ratio of 62.28 and a beta of 1.03.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.05. The firm had revenue of $466.80 million for the quarter, compared to analyst estimates of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%.

Innospec announced that its Board of Directors has initiated a stock repurchase plan on Monday, March 10th that authorizes the company to buyback $50.00 million in outstanding shares. This buyback authorization authorizes the specialty chemicals company to repurchase up to 2% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Insider Buying and Selling

In related news, SVP Corbin Barnes sold 2,692 shares of the company’s stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $278,083.60. Following the completion of the sale, the senior vice president now owns 8,051 shares of the company’s stock, valued at $831,668.30. This represents a 25.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Philip John Boon sold 3,754 shares of the firm’s stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $103.30, for a total transaction of $387,788.20. Following the completion of the transaction, the vice president now directly owns 20,079 shares in the company, valued at approximately $2,074,160.70. This represents a 15.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,696 shares of company stock valued at $794,853 over the last 90 days. 1.31% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Innospec

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Murphy & Mullick Capital Management Corp bought a new position in shares of Innospec in the 4th quarter valued at $106,000. Covestor Ltd grew its position in Innospec by 13.9% in the fourth quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company’s stock valued at $106,000 after acquiring an additional 118 shares during the last quarter. KBC Group NV raised its stake in Innospec by 82.3% during the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock worth $136,000 after acquiring an additional 558 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Innospec by 54.2% in the fourth quarter. Blue Trust Inc. now owns 1,201 shares of the specialty chemicals company’s stock worth $136,000 after acquiring an additional 422 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Innospec by 91.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,802 shares of the specialty chemicals company’s stock worth $198,000 after acquiring an additional 863 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.